We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.33%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,055

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TRVI icon
3401
Trevi Therapeutics
TRVI
$2.54B
– –
-128,324
Closed -$198K
TSLX icon
3402
Sixth Street Specialty
TSLX
$1.79B
– –
-167,516
Closed -$2.74M
TSQ icon
3403
Townsquare Media
TSQ
$108M
– –
-10,902
Closed -$79K
TTEC icon
3404
TTEC Holdings
TTEC
$113M
– –
-65,182
Closed -$2.89M
TTSH
3405
DELISTED
Tile Shop Holdings
TTSH
– –
-10,964
Closed -$38K
TYGO icon
3406
Tigo Energy
TYGO
$90.6M
– –
-490,615
Closed -$4.93M
UBX
3407
DELISTED
Unity Biotechnology
UBX
– –
-41,046
Closed -$165K
UDMY
3408
DELISTED
Udemy
UDMY
– –
-192,733
Closed -$2.33M
UDR icon
3409
UDR
UDR
$12.1B
– –
-98,668
Closed -$4.12M
UFI icon
3410
UNIFI
UFI
$129M
– –
-44,870
Closed -$427K
UHS icon
3411
Universal Health Services
UHS
$10.5B
– –
-11,974
Closed -$1.06M
UNTY icon
3412
Unity Bancorp
UNTY
$598M
– –
-9,582
Closed -$241K
UPBD icon
3413
Upbound Group
UPBD
$1.12B
– –
-318,218
Closed -$5.57M
USPH icon
3414
US Physical Therapy
USPH
$1.24B
– –
-11,155
Closed -$847K
VBTX
3415
DELISTED
Veritex Holdings
VBTX
– –
-44,645
Closed -$1.19M
VC icon
3416
Visteon
VC
$2.8B
– –
-3,925
Closed -$416K
VCEL icon
3417
Vericel Corp
VCEL
$2.25B
– –
-249,317
Closed -$5.78M
VDC icon
3418
Vanguard Consumer Staples ETF
VDC
$7.94B
– –
-4,100
Closed -$704K
VGT icon
3419
Vanguard Information Technology ETF
VGT
$147B
– –
-149,608
Closed -$5.75M
VHC icon
3420
VirnetX Holding Corp
VHC
$60.1M
– –
-21,921
Closed -$513K
VIPS icon
3421
Vipshop
VIPS
$7.4B
– –
-320,500
Closed -$2.7M
VIRT icon
3422
Virtu Financial
VIRT
$4.92B
– –
-24,579
Closed -$510K
VMD icon
3423
Viemed Healthcare
VMD
$355M
– –
-140,687
Closed -$844K
VNET
3424
VNET Group
VNET
$2.13B
– –
-22,300
Closed -$123K
VOX icon
3425
Vanguard Communication Services ETF
VOX
$5.88B
– –
-4,300
Closed -$355K
135 136
137
138 139

Similar funds

VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,055 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,055 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.